Endoplasmic reticulum stress in breast cancer: a predictive model for prognosis and therapy selection.

Authors:
Yang B; Wang S; Yang Y; Li X; Yu F and 1 more

Journal:
Front Immunol

Publication Year: 2024

DOI:
10.3389/fimmu.2024.1332942

PMCID:
PMC10910050

PMID:
38440732

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Front Immunol

Abbreviation: Front Immunol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Allergy and Immunology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
2'-deoxy-ADPR activates human TRPM2 faster than ADPR and thereby induces higher currents at physiol…
Pick J; Sander S; Etzold S and 4 more (2024) - Transparency Score: 3/6
Aberrant NK cell profile in gestational diabetes mellitus with fetal growth restriction.
Xiong Y; Wang Y; Wu M and 10 more (2024) - Transparency Score: 4/6
Abnormal functional lymphoid tolerance and enhanced myeloid exocytosis are characteristics of resti…
Gaudin C; Ghinnagow R; Lemaire F and 3 more (2024) - Transparency Score: 3/6
A brief review of the current status of pig islet xenotransplantation.
Cooper DKC; Mou L; Bottino R. (2024) - Transparency Score: 3/6
A candidate glycoconjugate vaccine induces protective antibodies in the serum and intestinal secret…
Haldar R; Dhar A; Ganguli D and 5 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."

Evidence found in paper:

"The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This study was supported by the Talent Fund of Guizhou Provincial People’s Hospital ([2022]-33), Guiyang Bureau of Science and Technology major special program ([2022]-4-1), and Doctor Fund of Guizhou Provincial People’s Hospital (GSYSBS[2016]-1)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025